Advancing Antimicrobial Stewardship

OtoNexus Medical Technologies is developing a breakthrough device that will provide clinicians the information they need to instantly and accurately diagnose and treat middle ear infections. Definitive and objective diagnostic data identifying the type of infection will lead to improved patient outcomes, better and faster treatment, reduced antibiotic usage and significantly reduced healthcare costs.

A Personal Message from Caitlin Cameron, Chair and CEO

OtoNexus Medical Technologies is in the late stages of developing the world’s first medical device to instantly and accurately diagnose middle ear infections (Otitis Media) in children and adults.

By accurately identifying the type of infection, as well as other states, diagnostic uncertainty is removed, and pediatricians and parents can be confident in determining antibiotic use, dramatically reducing unnecessary antibiotics and their long-term consequences.

Our inexpensive advanced ultrasound otoscope provides data in seconds and is easy to use by physicians or non-physician personnel worldwide. Definitive, objective data will lead to improved patient outcomes, better and faster treatment, reduced antibiotic usage and significantly reduced healthcare costs.

We fill a huge gap and provide positive incentives to all parties involved, pediatricians, parents, insurance carriers and medical societies; all understand the benefits of improved patient outcomes, reduced cost and antimicrobial stewardship.

This revolutionary device will reinvent the ear exam.

I hope you will join us.

Support and Funding